Access: Novartis Gives It Away

Article

Pharmaceutical Executive

Pharmaceutical ExecutivePharmaceutical Executive-07-01-2001
Volume 0
Issue 0

Basel, Switzerland -Novartis plans to provide its malaria drug, Coartem (artemether/lumefantrin), at cost to developing countries in partnership with the World Health Organization (WHO). The effort is only the latest in a series of moves intended to increase access to essential medicines after Big Pharma’s South Africa debacle.

Recent Videos
Lynlee Brown
Arda Ural
Lynlee Brown
Ted Sweetser
Ted Sweetser
Ted Sweetser
Related Content